Share new trends in technology and health
Share new trends in technology and health

Guangdong HEC Lake Pharma Co., Ltd. successfully signed a contract with Dongguan Biotechnology Company and Songshan Lake Science City Company

2021-04-09


On the afternoon of April 7, 2021, Guangdong Sunshine Lake Pharma Co., Ltd. (hereinafter referred to as "Guangdong HEC Lake Pharma ") successfully held a project signing ceremony with Dongguan Biotechnology Industry Development Co., Ltd. and Dongguan Songshan Lake Science City Development Group Co., Ltd. , Songshan Lake will fully support the accelerated growth of Guangdong Sunshine Lake Pharma Co., Ltd. Deputy Secretary of the Songshan Lake Party Working Committee and Director of the Management Committee Ouyang Nanjiang, Member of the Songshan Lake Party Working Committee and Member of the Management Committee Chen Xihua, Chairman of Dongguan Biotechnology Industry Development Co., Ltd. Song Tao. Chairman of Songshan Lake Science City Development Group Ye Zhenhui, Chairman of HEC Group Zhang Yushuai, General Manager Tang Xinfa, Deputy General Manager Deng Xinhua, Chairman of Guangdong HEC Pharmaceuticals Zhang Yingjun and other leaders and guests attended the signing ceremony.

At the signing ceremony, the general manager of the group, Tang Xinfa, said that HEC Group would like to express its gratitude to the Songshan Lake Management Committee, the Biotechnology Company and the Science City Company for their strong support. In the future, Guangdong Sunshine Lake Pharma would continue to cultivate Songshan Lake, focus on the biomedical industry, and strive to become a benchmark enterprise in the biomedical sector with a market value of 100 billion, and contribute to the development of Songshan Lake.

Dongguan Biotechnology Industry Development Co., Ltd. (hereinafter referred to as "Biotechnology Company") is a wholly state-owned company of Songshan Lake Garden, which comprehensively operates the biotechnology industry platform on both sides of the Taiwan Strait. Relying on the biotechnology industry of Songshan Lake, the government, policies, funds, projects and other resources are integrated to carry out business such as industrial city development, industrial investment, industrial R&D production, and industrial services. It has rich resources in the field of biotechnology and is the sponsor of Dongguan Biotechnology Industry Association.

Dongguan Songshan Lake Science City Development Group Co., Ltd. (hereinafter referred to as "Science City Company") is a wholly state-owned company of Songshan Lake Park in Dongguan City. It will be built into a comprehensive investment and operation service platform for Songshan Lake Science City. , Through the development and investment of scientific and technological projects, it supports enterprises in Songshan Lake Park to become bigger and stronger, is committed to promoting the high-quality development of Songshan Lake Science City.

Guangdong Sunshine Lake Pharma is a pharmaceutical innovation R&D enterprise in the biopharmaceutical sector of the HEC Group. It is registered in Songshan Lake, Dongguan. It is a comprehensive pharmaceutical platform integrating R&D, preclinical and clinical development, drug registration, production and sales, and is committed to the global development and commercialization of innovative small molecule drugs, innovative biological drugs and similar drugs, as well as first generic drugs and innovative preparations. The company has more than 20 foreign and returnee experts, more than 100 doctors, more than 1,500 masters, more than 1,700 R&D personnel, more than 200 R&D projects, and has a State Key Laboratory of Anti-infective New Drug Development certified by the Ministry of Science and Technology, it undertakes a number of major national special projects, and the R & D pipeline is extremely rich. It is one of the pharmaceutical companies with the strongest R&D capability in Guangdong Province. The company's core advantage lies in the advantages of the entire industrial chain that runs through the R&D, production and sales of innovative drugs, and has now entered the first echelon of my country's innovative drug industry.

On February 26 this year, Dongguan held a high-level mobilization meeting to promote the construction of strategic emerging industry bases, focusing on 7 major strategic emerging industries, laying out 7 major strategic emerging industry bases, creating a batch of 100 billion-level strategic emerging industry clusters, building new kinetic energy to support future development. Among them, the biopharmaceutical industry base is located in Songshan Lake, and Songshan Lake is making every effort to promote the development of the biotechnology industry. The investment by the Biotechnology Company and the Science City Company in Guangdong Sunshine Lake Pharma shows the importance attached by the Dongguan Municipal Government and the Songshan Lake Management Committee to the biopharmaceutical industry and the recognition of Guangdong Sunshine Lake Pharma Invest to accelerate the pace of development of HEC Pharmaceutical, and support leading enterprises to accelerate their development. Guangdong Sunshine Lake Pharma is actively seeking to be listed on the domestic and overseas stock markets, further improving and strengthening the company's business, setting up a benchmark for the biomedical sector in the park, and contributing to the high-quality development of the pharmaceutical industry in Songshan Lake Park!

After the signing ceremony was completed, all the leaders and guests visited the HEC Pharmaceutical Research Institute.

Related news

The 3rd meeting of the 9th board of directors of HEC Group and the collective training and study of "thinking change, sunshine century" of the management committee were successfully held in Zhuhai, Gu

2021-06-03

On April 24, 2021, the third meeting of the ninth board of directors of HEC Group was successfully held in Zhuhai, Guangdong. Group Chairman Zhang Yushuai, Group Directors Tang Xinfa, Lu Yuxin, Zhu Yingwei, Zhang Hongwei, Deng Xinhua attended the meeting, and Group Supervisors Hu Zhidong, Zhou Lin, Wei Cailiang and Assistant Wen Xinting attended the meeting.